New Fortress Energy
NFE
德康医疗
DXCM
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
4
eBay
EBAY
5
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
美股市场个股详情
RVMD Revolution Medicines
- 37.440
- -2.355-5.92%
收盘价 05/06 16:00 (美东)
- 37.510
- +0.070+0.19%
盘前 04:10 (美东)
69.61亿总市值-10.46市盈率TTM
39.600最高价36.360最低价308.94万股成交量39.330今开39.795昨收1.16亿成交额1.84%换手率亏损市盈率(静)1.86亿总股本62.40052周最高3.07市净率62.98亿流通值29.17052周最低--股息TTM1.68亿流通股62.400历史最高--股息率TTM8.14%振幅14.080历史最低37.657平均价1股每手
关于Revolution Medicines公司
Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。 该公司的产品包括RMC-4630，SHP2抑制剂，RAS（ON） 产品组合以及SOS1和4EBP1 / mTORC1程序。
公司介绍
公司代码RVMD
公司名称Revolution Medicines
上市日期2020/02/13
发行价格17.00
成立日期2004
CEODr. Mark A. Goldsmith, M.D., PhD
所属市场纳斯达克
员工数量534
年结日12-31
公司地址700 Saginaw Drive
城市Redwood City
省份加利福尼亚州
国家美国
邮编94063
电话1-650-481-6801
董事高管
- 姓名
- 职务
- 年薪
- Dr. Mark A. Goldsmith, M.D., PhD
- President, Chief Executive Officer and Chairman of the Board
- 1007.95万
- Margaret A. Horn, J.D.
- Chief Operating Officer
- 488.44万
- Jack Anders
- Chief Financial Officer and Principal Accounting Officer
- 329.25万
- Dr. Wei Lin, M.D.
- Chief Medical Officer
- --
- Ryan Asay
- Senior Vice President, Corporate Affairs
- --
- Dr. Mason Shih, M.D.
- Senior Vice President, Head of Drug Safety
- --
- Dr. Mary Pinder-Schenck, M.D.
- Senior Vice President, Head of Medical Affairs
- --
- Dr. Jing Yi, PhD
- Senior Vice President, Head of Program Leadership.
- --
- Xiaolin Wang
- Executive Vice President, Development
- 305.42万
- Jeff Cislini
- Senior Vice President, General Counsel and Secretary
- --
- Dr. Stephen M. Kelsey, F.R.C.P.,M.D.
- President, Research and Development
- 594.96万
- Elizabeth McKee Anderson, M.B.A.
- Independent Director
- 59.31万
- Frank K. Clyburn, Jr
- Independent Director
- 102.45万
- Alexis A. Borisy, A.M.
- Lead Independent Director
- 61.84万
- Dr. Thilo Schroeder, PhD
- Independent Director
- --
- Dr. Sushil Patel, PhD
- Independent Director
- 59.13万
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 40.17万
- Dr. Lorence H. Kim, M.D.
- Independent Director
- 60.60万
- Dr. Flavia Borellini, PhD
- Independent Director
- 59.85万
- Dr. Barbara L. Weber, M.D.
- Independent Director
- 58.85万
热门市场机会
热门讨论
贸易战升级，中国股市何去何从？
🎙️讨论： 1. 中欧电动汽车谈判最近开始。这些谈判将如何影响相关股票的表现？ 2. 在当前贸易紧张局势下，你会如何调整对中国股票的投资策略？
Moo Earnings
02/17 19:21
阿里巴巴2024财年第四季度业绩预览：预测并赢得丰厚奖励！🚀